The S&P/ASX 200 Index (Index:^AXJO) is likely to trade water in the near term as bargain buys are getting increasingly hard to find after the market bounce.
Investors are sitting on their hands as they await greater clarity on the impact of COVID-19 on company earnings.
The S&P/ASX 200 Index (Index:^AXJO) is likely to trade water in the near term as bargain buys are getting increasingly hard to find after the market bounce.
Investors are sitting on their hands as they await greater clarity on the impact of COVID-19 on company earnings.
But there are a number of overlooked value stocks on the market, according to some of our leading brokers who have just upgraded these ASX shares to “buy”.
Even bad news has a price
One stock that is now looking attractive is Australian Pharmaceutical Industries Ltd (ASX: API), according to Citigroup.
This is despite the health and beauty group posting a disappointing first half result yesterday.
What’s more, the period covered doesn’t include the coronavirus impact, but yet its Priceline, ClearSkin and Consumer Brands businesses delivered earnings that were below what the broker was expecting.
But there’s too much bad news now factored into the API share price after its 22% plunge since the start of the year.
This was enough to convince Citi to upgrade the stock to “buy” from “neutral” even as the broker cut its price target to $1.15 from $1.40 a share.
Positioned for further gains
Another stock that just got put on the upgraded list is McPherson’s Ltd (ASX: MCP). Shaw and Partners lifted its rating on the beauty and household products supplier to “buy” after management’s recent trading update.
“The company has re-iterated guidance (which could be conservative), paid an interim dividend, has a strong balance sheet and multiple products/segments growing. A strong position to be in,” said Shaw.
“MCP is trading at a discount of 33% to HW&B peers with above market growth and a conservative balance sheet.
“Re-iteration of guidance and acceleration leading into FY21 bodes positively for a continued re-rating and we see potential for M&A to augment this earnings stream in the near term as MCP can act opportunistically.”
The broker’s price target on McPherson’s is $3.12 a share.
Engineered for value
Meanwhile, Goldman Sachs believes listed engineering contractors leveraged to the mining industry will outperform in this coronavirus-hit market.
“We continue to recommend investors target production exposure within mining services, with quarterlies reaffirming miner intentions to maintain healthy output in the current backdrop,” said the broker.
The stock in this sector that got promoted to a “buy” is Australia’s largest mining equipment rental firm Emeco Holdings Limited (ASX: EHL).
The broker’s price target on Emeco is $1.30 a share.
NEW! 5 Cheap Stocks With Massive Upside Potential
Our experts at The Motley Fool have just released a FREE report detailing 5 shares you can buy now to take advantage of the much cheaper share prices on offer.
One is a diversified conglomerate trading 40% off it’s all time high, all while offering a fully franked dividend yield of over 3%…
Another is a former stock market darling that is one of Australia’s most popular and iconic businesses. Trading at a significant discount to its 52-week high, not only does this stock offer massive upside potential, but it also trades on an attractive fully franked dividend yield of almost 4%.
Plus, this free report highlights 3 more cheap bets that could position you to profit in 2020 and beyond.
Simply click here to scoop up your FREE copy and discover the names of all 5 cheap shares.
But you will have to hurry because the cheap share prices on offer today might not last for long.
Returns as of 7/4/2020
Motley Fool contributor Brendon Lau has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.